Prognostic significance of the systemic inflammatory and immune balance in alcoholic liver disease with a focus on gender-related differences

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Kasztelan Szczerbińska, Beata ^a   Surdacka, Agata ^a   Celiński, Krzysztof ^a   Roliński, Jacek ^a   Zwolak, Agnieszka ^a   Miącz, Sławomir ^b   Szczerbiński, Mariusz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Department of Surgery   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; CYTOKINE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; SEX DIFFERENCE; SURVIVAL TIME; TH17 CELL; BLOOD; IMMUNOLOGY; LIVER; MIDDLE AGED; PATHOLOGY; SEXUAL DEVELOPMENT;

CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; PROGNOSIS; SEX CHARACTERISTICS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84939207955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128347     Document Type: Article

References (64)

1. World Health Organisation. Global Status Raport on Alcohol and Health 2011. Geneva, Switzerland: World Health Organisation, 2011.
2. Paula H, Asrani SK, Boetticher NC, Pedersen R, Shah VH, Kim WR. Alcoholic liver disease-related mortality in the United States: 1980-2003 Am J Gastroenterol. 2010, 105(8):1782-7. doi: 10.1038/ajg.2010.46 PMID: 20179691
3. Curtis BJ, Hlavin S, Brubaker AL, Kovacs EJ, Radek KA. Episodic binge ethanol exposure impairs murine macrophage infiltration and delays wound closure by promoting defects in early innate immune responses. Alcohol Clin Exp Res. 2014; 38(5):1347-55. doi: 10.1111/acer.12369 PMID: 24689549
4. Ward RJ, Lallemand F, de Witte P. Influence of adolescent heavy session drinking on the systemic and brain innate immune system. Alcohol Alcohol 2014; 49(2):193-7. doi: 10.1093/alcalc/agu002 PMID: 24532587
5. Szabo G, Mandrekar P, Petrasek J, Catalano D. The unfolding web of innate immune dysregulation in alcoholic liver injury. Alcohol Clin Exp Res. 2011; 35(5):782-6. doi: 10.1111/j.1530-0277.2010.01398.x PMID: 21284666
6. Szabo G, Petrasek J, Bala S. Innate immunity and alcoholic liver disease. Dig Dis. 2012; 30 Suppl 1:55-60. doi: 10.1159/000341126 PMID: 23075869
7. Szabo G, Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res 2009; 33(2):220-232. doi: 10.1111/j.1530-0277.2008.00842.x PMID: 19053973
8. Viitala K, Makkonen K, Israel Y, Lehtimäki T, Jaakkola O, Koivula T et al. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers. Alcohol Clin Exp Res. 2000; 24(7):1103-9. PMID: 10924016
9. Li J, Qiu SJ, She WM, Wang FP, Gao H, Li L et al. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS One. 2012; 7(6):e39307. doi: 10.1371/journal.pone.0039307 PMID: 22745730
10. Liu LL, Qin Y, Cai JF, Wang HY, Tao JL, Li H et al. Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome. Clin Immunol. 2011; 139(3):314-20. doi: 10.1016/j.clim.2011.02.018 PMID: 21450528
11. Wang W, Shao S, Jiao Z, Guo M, Xu H, Wang S. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int. 2012; 32(4):887-93. doi: 10.1007/s00296-010-1710-0 PMID: 21221592
12. Zhao L, Yang J, Wang HP, Liu RY. Imbalance in the Th17/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma. Med Oncol. 2013; 30(1):461. doi: 10.1007/s12032-013-0461-7 PMID: 23335103
13. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009; 27:485-517. doi: 10.1146/annurev.immunol.021908.132710 PMID: 19132915
14. Corthay A. How do Regulatory T Cells Work? Scand J Immunol. 2009 Oct; 70(4): 326-336. doi: 10.1111/j.1365-3083.2009.02308.x PMID: 19751267
15. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. PMID: 16648838
16. Piccioni M, Chen Z, Tsun A, Li B. Regulatory T-cell differentiation and their function in immune regulation. Adv Exp Med Biol. 2014; 841:67-97. doi: 10.1007/978-94-017-9487-9-4 PMID: 25261205
17. Song X, Gao H, Qian Y. Th17 differentiation and their pro-inflammation function. Adv Exp Med Biol. 2014; 841:99-151. doi: 10.1007/978-94-017-9487-9-5 PMID: 25261206
18. Durazzo M, Belci P, Collo A, Prandi V, Pistone E, Martorana M et al. Gender specific medicine in liver diseases: a point of view. World J Gastroenterol. 2014; 20(9):2127-35. doi: 10.3748/wjg.v20.i9.2127 PMID: 24605011
19. Kovacs EJ, Messingham KA. Influence of alcohol and gender on immune response. Alcohol Res Health. 2002; 26(4):257-63. PMID: 12875035
20. Kasztelan-Szczerbinska B, Surdacka A, Slomka M, Rolinski J, Celinski K, Smolen A et al. Association of serum adiponectin, leptin, and resistin concentrations with the severity of liver dysfunction and the disease complications in alcoholic liver disease. Mediators Inflamm. 2013; 2013:148526. doi: 10.1155/2013/148526 PMID: 24259947
21. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT The Alcohol Use Disorders. Identification Test Guidelines for Use in Primary Care. 2nd ed. World Health Organisation. Geneva, 2001.
22. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 649-9. PMID: 4541914
23. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007; 45(3):797-805. PMID: 17326206
24. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 2002, 35 (3): 716-21. PMID: 11870389
25. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44(3):837-45. PMID: 3203132
26. Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology 2005; 16(1):73-81. PMID: 15613948
27. Nolen-Hoeksema S. Gender differences in risk factors and consequences for alcohol use and problems. Clin Psychol Rev. 2004; 24(8):981-1010. PMID: 15533281
28. Dettling A, Fischer F, Böhler S, Ulrichs F, Skopp G, Graw M et al. Ethanol elimination rates in men and women in consideration of the calculated liver weight. Alcohol. 2007; 41(6):415-20. PMID: 17936510
29. Eagon PK. Alcoholic liver injury: influence of gender and hormones. World J Gastroenterol. 2010; 16(11):1377-84. PMID: 20238405
30. Farcomeni A, Ventura L. An overview of robust methods in medical research. Stat Methods Med Res, 2012; 21(2):111-33. doi: 10.1177/0962280210385865 PMID: 20974666
31. Qin G, Hotilovac L. Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic test. Stat Methods Med Res. 2008; 17(2): 207-21. doi: 10.1177/0962280207087173 PMID: 18426855
32. McClain CJ, Barve S, Barve S, Deaciuc I, Hill DB. Tumor necrosis factor and alcoholic liver disease. Alcohol Clin Exp Res. 1998; 22(5 Suppl):248S-252S. PMID: 9727645
33. Lemmers A, Moreno C, Gustot T, Maréchal R, Degré D, Demetter P et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009; 49(2):646-57. doi: 10.1002/hep.22680 PMID: 19177575
34. Wang L, Chen S, Xu K. IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis. Int J Mol Med. 2011; 27(3):385-92. doi: 10.3892/ijmm.2011.594 PMID: 21225222
35. Chang Q, Wang YK, Zhao Q, Wang CZ, Hu YZ, Wu BY. Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2012; 27(2):273-8. doi: 10.1111/j.1440-1746.2011.06782.x PMID: 21592230
36. Yang CY, Ma X, Tsuneyama K, Huang S, Takahashi T, Chalasani NP et al. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology. 2014; 59(5):1944-53. doi: 10.1002/hep.26979 PMID: 24375552
37. Støy S, Sandahl TD, Dige AK, Agnholt J, Rasmussen TK, Grønbæk H et al. Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course. PLoS One. 2013; 8(1):55101.
38. Xing Q, Wang B, Su H, Cui J, Li J. Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int. 2012; 32(4):949-58. doi: 10.1007/s00296-010-1771-0 PMID: 21243492
39. Rollnik JD, Sindern E, Schweppe C, Malin JP. Biologically active TGF-beta1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients. Acta Neurol Scand. 1997; 96(2):101-5. PMID: 9272186
40. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun. 2000; 14(1):23-42. PMID: 10648114
41. Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011; 140(7):1952-60. doi: 10.1053/j.gastro.2011.02.017 PMID: 21334338
42. Lim YS, Larson TS, Benson JT, Kamath PS, Kremers WK, Therneau TM et al. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol. 2010; 52(4):523-8. doi: 10.1016/j.jhep.2010.01.009 PMID: 20185195
43. Sheron N, Bird G, Goka J, Alexander G, Williams R. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol. 1991; 84(3):449-53. PMID: 2044224
44. Zhang X, Tachibana S, Wang H, Hisada M, Williams GM, Gao B et al. Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice. Hepatology. 2010; 52:2137-47. doi: 10.1002/hep.23909 PMID: 20931558
45. El-Assal O, Hong F, Kim WH, Radaeva S, Gao B. IL-6-deficient mice are susceptible to ethanolinduced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell Mol Immunol. 2004; 1:205-11. PMID: 16219169
46. Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res. 2011; 35(5):787-93. doi: 10.1111/j.1530-0277.2010.01399.x PMID: 21284667
47. Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol. 2012; 27 Suppl 2:89-93. doi: 10.1111/j.1440-1746.2011.07003.x PMID: 22320924
48. Tilg H, Jalan R, Kaser A, Davies NA, Offner FA, Hodges SJ et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol. 2003; 38(4):419-25. PMID: 12663232
49. Naveau S, Chollet-Martin S, Dharancy S, Mathurin P, Jouet P, Piquet MA et al. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004; 39:1390-7. PMID: 15122768
50. Ma X, Hua J, Mohamood AR, Hamad ARA, Ravi R, Li Z. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology. 2007; 46(5):1519-29. PMID: 17661402
51. Sun XF, Gu L, Deng WS, Xu Q. Impaired balance of T helper 17/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice. World J Gastroenterol. 2014; 28;20(8):2062-70. doi: 10.3748/wjg.v20.i8.2062 PMID: 24616573
52. Alunno A, Bartoloni E, Bistoni O, Nocentini G, Ronchetti S, Caterbi S et al. Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new. Clin Dev Immunol. 2012; 2012:823085. doi: 10.1155/2012/823085 PMID: 22761634
53. Huang H, Lu Z, Jiang C, Liu J, Wang Y, Xu Z. Imbalance between Th17 and regulatory T-Cells in sarcoidosis. Int J Mol Sci. 2013; 14(11):21463-73. doi: 10.3390/ijms141121463 PMID: 24177566
54. Li Q, Li Q, Chen J, Liu Y, Zhao X, Tan B et al. Prevalence of Th17 and Treg cells in gastric cancer patients and its correlation with clinical parameters. Oncol Rep. 2013; 30(3):1215-22. doi: 10.3892/or.2013.2570 PMID: 23807713
55. Ashley MJ, Olin JS, Le Riche WH, Kornaczewski A, Schmidt W, Rankin JG. Morbidity in alcoholics: evidence for accelerated development of physical disease in women. Arch Intern Med. 1977; 137:883-7. PMID: 879927
56. Loft S, Olesen K, Dossing M. Increased susceptibility to liver disease in relation to alcohol consumption in women. Scand J Gastroenterol. 1987; 22:1251-6. PMID: 3433014
57. Zakhari S., Li T.-K. Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease. Hepatology, 2007, 46: 2032-9. PMID: 18046720
58. Li TK, Yin SJ, Crabb DW, O'Connor S, Ramchandani VA. Genetic and environmental influences on alcohol metabolism in humans. Alcohol Clin Exp Res 2001; 25: 136-44. PMID: 11198709
59. Müller C. Liver, alcohol and gender. Wiener Medizinische Wochenschrift, 2006, 156(19-20), 523-6.
60. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J et al. Alcohol as a risk factor for liver cirrhosis: A systematic review and meta-analysis. Drug and alcohol review, 2010, 29(4), 437-45. doi: 10.1111/j.1465-3362.2009.00153.x PMID: 20636661
61. Ali AK, Jones JS, Bradley MP, Bhala N, Rahman A, Peck RJ et al. Familial predisposition to alcoholic liver disease: a case-control study. Eur J Gastroenterol Hepatol. 2012; 24(7):798-804. doi: 10.1097/MEG.0b013e328353a367 PMID: 22562113
62. Gleeson D, Jones JS, McFarlane E, Francis R, Gellion C, Bradley MP et al. Severity of alcohol dependence in decompensated alcoholic liver disease: comparison with heavy drinkers without liver disease and relationship to family drinking history. Alcohol Alcohol. 2009; 44(4):392-7. doi: 10.1093/alcalc/agp008 PMID: 19286679
63. Kerr WC, Stockwell T. Understanding standard drinks and drinking guidelines. Drug Alcohol Rev 2012; 31(2):200-5. doi: 10.1111/j.1465-3362.2011.00374.x PMID: 22050262
64. Stockwell T, Stirling L. Estimating alcohol content of drinks: common errors in applying the unit system. BMJ 1989; 298(6673):571-2. PMID: 2495119